|Free Dividend Report|
|Stock Splits Calendar|
|NBS Stock Split History|
|Preferred Stock Newsletter|
|NBS Options Chain|
|Stock Message Boards|
NBS (NBS) has 2 splits in our NBS split history database. The first split for NBS took place on August 09, 2007. This was a 1 for 10 reverse split, meaning for each 10 shares of NBS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. NBS's second split took place on July 16, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of NBS owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split.
When a company such as NBS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NBS split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NBS shares, starting with a $10,000 purchase of NBS, presented on a split-history-adjusted basis factoring in the complete NBS split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-33.53%|
|NeoStem is engaged in the development of proprietary cell therapy products, and operating a contract development and manufacturing organization providing services in the regenerative medicine industry. Co. is developing therapies to address ischemia through its CD34 Cell Program. AMR-001 is Co.'s product candidate in this program and is being developed to treat damaged heart muscle following an acute myocardial infarction (heart attack). Another platform technology Co. is developing uses T Regulatory Cells to treat diseases caused by imbalances in the immune system. In addition, pre-clinical assets include Co.'s VSEL™ (Very Small Embryonic Like) Technology regenerative medicine platform. According to our NBS split history records, NBS has had 2 splits.|
|NBS Split History Table|
|08/09/2007||1 for 10|
|07/16/2013||1 for 10|
|Healthcare Stock Splits|
|NBS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:|